Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 9, 2011, Pages 1352-1361

  Ahmed, Syed O A ^a   Ghavamzadeh, Ardeshir ^b   Zaidi, Syed Z ^c   Baldomero, Helen ^d   Pasquini, Marcelo C ^e   Hussain, Fazal ^a   Alimoghaddam, Kamran ^b   Almohareb, Fahad ^a   Ayas, Mouhab ^a   Hamidieh, Amir ^b   Mahmoud, Hossam K ^f   Elhaddad, Alaa ^f   Ben Othman, Tarek ^g   Abdelkefi, Abdelrahman ^g   Sarhan, Mahmoud ^h   Abdel Rahman, Fawzi ^h   Adil, Salman ⁱ   Alkindi, Salam ^j   Bazarbachi, Ali ^k   Benchekroun, Said ^l   Niederwieser, Dietger ^m   Horowitz, Mary ^e   Gratwohl, Alois ^d   El Solh, Hassan ^a   Aljurf, Mahmoud ^a   more..

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Prince Sultan Hematology Oncology Center   (Saudi Arabia)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^f CAIRO UNIVERSITY   (Egypt)

^g CENTRE NATIONAL DE GREFFE DE MOELLE OSSEUSE   (Tunisia)

^h KING HUSSEIN CANCER CENTER   (Jordan)

ⁱ AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^j SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

^k AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^l Service d'Hematologie et Oncologie Pediatrique   (Morocco)

^m UNIVERSITY HOSPITAL LEIPZIG   (Germany)

more..

Author keywords

Conditioning; EMRO; Hematopoietic stem cell transplantation; Stem cell source

Indexed keywords

ACUTE LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW DEPRESSION; CORD BLOOD STEM CELL TRANSPLANTATION; HEALTH SURVEY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINOPATHY; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MYELOMA; PERIPHERAL BLOOD STEM CELL; REDUCED INTENSITY CONDITIONING; SOUTHERN EUROPE; TREATMENT INDICATION; TREND STUDY; WORLD HEALTH ORGANIZATION;

BONE MARROW DISEASES; DATA COLLECTION; DATABASES, FACTUAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MEDITERRANEAN REGION; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 79961002454     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.01.019     Document Type: Article

References (29)

1. Copelan E.A. Hematopoietic stem-cell transplantation. N Engl J Med 2006, 354:1813-1826.
2. Horowitz M. The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research. Bone Marrow Transplant 2008, 42:S1-S2.
3. Accessed March 8, 2010. http://embmt.org/.
4. Aljurf M.D., Zaidi S.Z., Solh El, et al. Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report. Bone Marrow Transplant 2009, 43:1-12.
5. Mahmoud H., El-Haddad A.M., Fahmy O., et al. Hematopoietic stem cell transplantation in Egypt. Bone Marrow Transplant 2008, 42:S76-S80.
6. Ghavamzadeh A., Alimogaddam K., Jahani M., et al. Hematopoietic stem cell transplantation in Iran. Hematol Oncol Stem Cel Ther 2008, 1:231-238.
7. Gratwohl A., Baldomero H., Labar B., Apperley J., Urbano-Ispizua A. Evolution of hematopoietic stem cell transplantation in Eastern and Western Europe from 1990 to 2003. A report from the EBMT activity survey. Croatian Med J 2004, 45:689-694.
8. International Data Base - Country Rankings - US Census Bureau. Accessed March 8, 2010. http://www.census.gov/ipc/www/idb/rank.php.
9. Gratwohl A., Baldomero H., Frauendorfer K., Neiderwieser D. Why are there regional differences in stem cell activity?. Bone Marrow Transplant 2008, 42:S7-S10. for the Joint Accreditation Committee of the International Society for Cellular Therapy ISCT and the European Group for Blood and Marrow Transplantation EBMT (JACIE).
10. Gratwohl A., Passweg J., Baldomero H., Horisberger B., Urbano-Ispizua A. Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe. Br J Haematol 2002, 117:451-468. for the Joint Accreditation Committee of the European Group for Blood and Marrow Transplantation.
11. Svahn B.-M., Alvin O., Ringden O., Gardulf A., Remberger M. Costs of allogeneic hematopoietic stem cell transplantation. Transplantation 2006, 82:147-153.
12. Gratwohl A., Schmid O., Baldomero H., Horisberger B., Urbano-Ispizua A. Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey. Bone Marrow Transplant 2004, 34:855-875. for the Accreditation Committee of the European Group for Blood and Marrow Transplantation.
13. Klomp J., de Haan J. Is the political system really related to health?. Soc Sci Med 2009, 69:36-46.
14. Gratwohl A., Baldomero H., Schwendener A., et al. for the Joint Accreditation Committee of the International Society for Cellular Therapy ISCT and the European Group for Blood and Marrow Transplantation EBMT (JACIE). The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009, 43:275-291.
15. Pasquini MC, Wang Z. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides, 2010. Available at: Accessed January 1, 2011. http://www.cibmtr.org.
16. Urbano-Ispizua A., Schmitz N., de Witte T., et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 2002, 29:639-646.
17. Vogl D., Stadtmauer E. High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed. Bone Marrow Transplant 2006, 37:985-987.
18. Ayas M., Al-Jefri A., Al-Seraihi A., Elkum N., Al-Mahr M., El-Solh H. Matched-related allogeneic stem cell transplantation in Saudi patients with Fanconi anemia: 10 years' experience. Bone Marrow Transplant 2008, 42:S45-S48.
19. Ullah K., Khan B., Raza S., et al. Bone marrow transplant cure for ß-thalassaemia major: initial experience from a developing country. Ann Hematol 2008, 87:655-661.
20. Ghavamzadeh A., Nasseri P., Eshraghian M.R., et al. Prognostic factors in bone marrow transplantation in beta thalassemia major: experiences from Iran. Bone Marrow Transplant 1998, 22:1167-1169.
21. Goldman J. Allogeneic stem cell transplantation for chronic myeloid leukemia-status in 2007. Bone Marrow Transplant 2008, 42:S11-S13.
22. Gratwohl A., Baldomero H., Frauendorfer K., Urbano-Ispizua A. EBMT activity survey 2004 and changes in disease indication over the past 15 years. Bone Marrow Transplant 2006, 37:1069-1085. for the Joint Accreditation Committeee of the International Society for Cellular Therapy ISCT and the European Group for Blood and Marrow Transplantation EBMT (JACIE).
23. Confer D., Robinett P. The US National Marrow Donor Program role in unrelated donor hematopoietic stem cell transplantation. Bone Marrow Transplant 2008, 42:S3-S5.
24. Gratwohl A., Baldomero H., Schmid, et al. Change in stem cell source for haematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003. Bone Marrow Transplant 2005, 36:575-590.
25. Schmitz N., Bacigalupo A., Hasenclever D., et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomized multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998, 21:995-1003.
26. Champlin R., Schmitz N., Horowitz M., et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood 2000, 95:3702-3709.
27. Schmitz N., Beksac M., Bacigalupo A., et al. Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial. Haematologica 2005, 90:643-648.
28. Gratwohl A., Baldomero H., Frauendorfer K., Rocha V., Apperley J., Niederwieser D. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products. Bone Marrow Transplant 2008, 41:687-705. for the Joint Accreditation Committee of the International Society for Cellular Therapy ISCT and the European Group for Blood and Marrow Transplantation EBMT (JACIE).
29. Gajewski J.L., Lemaistre C.F., Silver S.M., et al. Impending challenges in the hematopoietic stem cell transplantation workforce. Biol. Blood Marrow Transplant 2009, 15:1493-1501.